Covestor Ltd - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.

Quarter-by-quarter ownership
Covestor Ltd ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$6
-14.3%
206
-0.5%
0.01%0.0%
Q2 2023$7
+40.0%
207
-1.0%
0.01%
+25.0%
Q1 2023$5
-68.8%
209
-50.0%
0.00%
-42.9%
Q4 2022$16
-99.8%
418
+106.9%
0.01%
+16.7%
Q3 2022$7,0000.0%202
-0.5%
0.01%0.0%
Q2 2022$7,000
-22.2%
203
-1.0%
0.01%0.0%
Q1 2022$9,000
+12.5%
205
+78.3%
0.01%
-45.5%
Q4 2021$8,0001150.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,303$54,386,00028.54%
JOHNSON & JOHNSON 3,260,869$216,196,00024.61%
ACT CAPITAL MANAGEMENT, LLC 210,500$13,956,00010.09%
Aquilo Capital Management, LLC 700,426$46,438,0005.27%
WEALTH EFFECTS LLC 145,960$9,677,0004.02%
Evolutionary Tree Capital Management, LLC 115,580$7,663,0003.68%
ACUTA CAPITAL PARTNERS, LLC 105,500$6,995,0002.94%
Privium Fund Management B.V. 204,393$13,766,0002.73%
L1 Capital Pty Ltd 292,735$19,408,0002.24%
Avidity Partners Management LP 875,000$58,013,0001.23%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders